全文获取类型
收费全文 | 34493篇 |
免费 | 3837篇 |
国内免费 | 1165篇 |
专业分类
耳鼻咽喉 | 165篇 |
儿科学 | 1905篇 |
妇产科学 | 749篇 |
基础医学 | 3125篇 |
口腔科学 | 806篇 |
临床医学 | 4149篇 |
内科学 | 5454篇 |
皮肤病学 | 235篇 |
神经病学 | 1795篇 |
特种医学 | 1389篇 |
外国民族医学 | 9篇 |
外科学 | 5379篇 |
综合类 | 4699篇 |
现状与发展 | 4篇 |
一般理论 | 1篇 |
预防医学 | 3402篇 |
眼科学 | 963篇 |
药学 | 2747篇 |
12篇 | |
中国医学 | 1076篇 |
肿瘤学 | 1431篇 |
出版年
2024年 | 53篇 |
2023年 | 554篇 |
2022年 | 816篇 |
2021年 | 1451篇 |
2020年 | 1361篇 |
2019年 | 1382篇 |
2018年 | 1328篇 |
2017年 | 1233篇 |
2016年 | 1205篇 |
2015年 | 1187篇 |
2014年 | 2195篇 |
2013年 | 2637篇 |
2012年 | 1940篇 |
2011年 | 2110篇 |
2010年 | 1706篇 |
2009年 | 1690篇 |
2008年 | 1783篇 |
2007年 | 1760篇 |
2006年 | 1595篇 |
2005年 | 1541篇 |
2004年 | 1321篇 |
2003年 | 1155篇 |
2002年 | 941篇 |
2001年 | 856篇 |
2000年 | 773篇 |
1999年 | 611篇 |
1998年 | 520篇 |
1997年 | 528篇 |
1996年 | 445篇 |
1995年 | 348篇 |
1994年 | 316篇 |
1993年 | 276篇 |
1992年 | 241篇 |
1991年 | 197篇 |
1990年 | 149篇 |
1989年 | 138篇 |
1988年 | 121篇 |
1987年 | 110篇 |
1986年 | 75篇 |
1985年 | 150篇 |
1984年 | 125篇 |
1983年 | 112篇 |
1982年 | 103篇 |
1981年 | 107篇 |
1980年 | 80篇 |
1979年 | 40篇 |
1978年 | 33篇 |
1977年 | 29篇 |
1976年 | 21篇 |
1975年 | 18篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
李晓兰 《菏泽医学专科学校学报》2015,(2):71-74
目的探讨发展性照顾对极低出生体重儿住院期间生长发育的影响。方法将新生儿重症监护病房收治的100例成活的极低出生体重儿随机分为观察组和对照组各50例,对照组采用常规护理,观察组采用发展性照顾,比较两组极低出生体重儿的住院情况、生长发育、相关并发症等。结果两组极低出生体重儿的胎龄、出生体重、出生头围等差异无显著性(P>0.05);恢复出生体重的时间、达到全肠内营养时间、平均住院的天数均少于对照组(P﹤0.01);每日睡眠时间大于对照组(P>0.01);观察组恢复出生体重后平均体重增长率、每周头围增长的速度、每周身长增长的速度均快于对照组(P>0.01);呼吸暂停、喂养不耐受、坏死性小肠结肠炎、早产儿视网膜病的发生率均少于对照组(P>0.01)。结论发展性照顾护理模式能加快极低出生体重儿的生长发育,缩短住院时间,减少并发症,提高患者生存质量。 相似文献
992.
G. M. Downes M. Lausberg B. M. Potts D. L. Pilbeam M. Bird B. Bradshaw 《Australian forestry.》2018,81(3):177-185
Average bark-to-bark resistance of the IML Resistograph PD400 (hereafter referred to as ‘Resi’) was found to provide strong linear correlations with the basic density of 12-mm-diameter increment cores taken from standing plantation eucalypt trees. Relationships between Resi values and approximately 2 000 cores (predominantly Eucalyptus globulus but some E. nitens) were examined across seven studies (representing samples from nine distinct sites) in Tasmania, Victoria and Western Australia. Custom-written software was developed to process the Resi traces to automatically perform a linear baseline correction of the trace, and extract:
over-bark and under-bark diameter
bark thickness
average resistance of the bark-to-bark (under-bark) trace
average resistance of the outer 50 mm on the entry and exit side of the traces.
993.
目的:探讨诱导血红素氧合酶-1(hemeoxygenase-1,HO-1)与氧化低密度脂蛋白(oxidizedlowdensity lipoprotein,ox-LDL)在动脉粥样硬化(atherosclerosis,AS)发生中的作用.方法:利用高脂饮食法建立大鼠动脉粥样硬化模型,40只Wistar大鼠随机均分为4组:对照组(A组)、单纯高脂饲料组(B组)、银杏叶提取物(extract of ginkgo biloba,EGB)组(C组)及锌原卟啉(Zinc protoporphyrinⅨ,ZnPPⅨ)组(D组),应用免疫组织化学染色法检测HO-1蛋白的表达,采用ELISA法测定大鼠血浆中oX-LDL的含量.结果:与A、B、D组相比,C组HO-1蛋白阳性表达程度最强,差异具有统计学意义(P<0.05);与A、B、C组相比,D组ox-LDL蛋白的含量最高,差异具有统计学意义(P<0.05);分析动脉粥样硬化中HO-1蛋白表达与ox-LDL含量之间的关系,发现二者呈负相关(P<0.05).结论:EGB诱导HO-1蛋白的表达抑制ox-LDL表达,而ZnPPⅨ抑制HPO-1蛋白表达促进ox-LDL表达.因此,可以选用HO-1蛋白诱导剂来下调ox-LDL蛋白的表达实现抑制动脉粥样硬化的目的. 相似文献
994.
Iftikhar J. Kullo Janet Olson Xiao Fan Merin Jose Maya Safarova Carmen Radecki Breitkopf Erin Winkler David C. Kochan Sara Snipes Joel E. Pacyna Meaghan Carney Christopher G. Chute Jyoti Gupta Sheethal Jose Eric Venner Mullai Murugan Yunyun Jiang Magdi Zordok Stephen N. Thibodeau 《Mayo Clinic proceedings. Mayo Clinic》2018,93(11):1600-1610
Objectives
To identify clinically actionable genetic variants from targeted sequencing of 68 disease-related genes, estimate their penetrance, and assess the impact of disclosing results to participants and providers.Patients and Methods
The Return of Actionable Variants Empirical (RAVE) Study investigates outcomes following the return of pathogenic/likely pathogenic (P/LP) variants in 68 disease-related genes. The study was initiated in December 2016 and is ongoing. Targeted sequencing was performed in 2533 individuals with hyperlipidemia or colon polyps. The electronic health records (EHRs) of participants carrying P/LP variants in 36 cardiovascular disease (CVD) genes were manually reviewed to ascertain the presence of relevant traits. Clinical outcomes, health care utilization, family communication, and ethical and psychosocial implications of disclosure of genomic results are being assessed by surveys, telephone interviews, and EHR review.Results
Of 29,208 variants in the 68 genes, 1915 were rare (frequency <1%) and putatively functional, and 102 of these (60 in 36 CVD genes) were labeled P/LP based on the American College of Medical Genetics and Genomics framework. Manual review of the EHRs of participants (n=73 with P/LP variants in CVD genes) revealed that 33 had the expected trait(s); however, only 6 of 45 participants with non–familial hypercholesterolemia (FH) P/LP variants had the expected traits.Conclusion
Expected traits were present in 13% of participants with P/LP variants in non-FH CVD genes, suggesting low penetrance; this estimate may change with additional testing performed as part of the clinical evaluation. Ongoing analyses of the RAVE Study will inform best practices for genomic medicine. 相似文献995.
Gregory Knell Qing Li Kelley Pettee Gabriel Kerem Shuval 《Mayo Clinic proceedings. Mayo Clinic》2018,93(11):1611-1616
More than two-thirds of American adults are overweight or obese, with many attempting to lose weight to avoid adverse health outcomes and improve well-being. Achieving long-term weight loss (LTWL) success, defined as reaching at least a 5% to 10% weight loss goal, is challenging, yet important for overall metabolic health. It is currently unclear whether achieving higher thresholds of LTWL is associated with improved health. Therefore, the purpose of this study was to examine the association between LTWL thresholds (5%-9.9%, 10%-14.9%, 15%-19.9%, ≥20%) and metabolic health (metabolic syndrome and metabolic risk z score) among 7670 US adult respondents to the National Health and Nutrition Examination Survey (2007-2014) who were overweight or obese (past or present), were not underweight in the past year, not pregnant, and attempting to lose or maintain weight. A subsample of 3362 participants was used in the analysis of the metabolic risk z score. Multivariable regression models were constructed adjusting for covariates. Results indicate that the lowest and the 2 highest LTWL thresholds were related to lower odds for metabolic syndrome; for example, greater than or equal to 20% LTWL (odds ratio=0.52; 95% CI, 0.23-0.44; P<.001). All LTWL thresholds were significantly associated with the metabolic risk z score, with the largest effect among the 2 highest LTWL thresholds, that is, 15% to 19.9% LTWL (β=?0.45; 95% CI, ?0.54 to ?0.36; P<.001) and greater than or equal to 20% LTWL (β=?0.35; 95% CI, ?0.53 to ?0.17; P<.001). In conclusion, although achieving the currently recommended LTWL target was related to improved metabolic health, the 15% LTWL threshold was associated with more favorable outcomes. 相似文献
996.
Cathleen S. Colón-Emeric Carl F. Pieper Courtney H. Van Houtven Janet M. Grubber Kenneth W. Lyles Joanne Lafleur Robert A. Adler 《Mayo Clinic proceedings. Mayo Clinic》2018,93(12):1749-1759
Objective
To determine the association between dual-energy x-ray absorptiometry (DXA) testing for osteoporosis and subsequent fractures in US male veterans without a previous fracture.Patients and Methods
This is a propensity score–matched observational study using Centers for Medicare and Medicaid Services and Veterans Affairs (VA) data from January 1, 2000, through December 31, 2010, with a mean follow-up time of 4.7 years (range, 0-10 years). Men receiving VA primary care aged 65 to 99 years without a previous fracture (N=2,539,812) were included. Men undergoing DXA testing were propensity score matched with untested controls in a 1:3 ratio, indicating the probability of DXA testing within the next year. Time to first clinical fracture was the primary outcome. Comorbidities, demographic characteristics, medications, DXA results, and osteoporosis treatment were defined using administrative data and natural language processing. A landmark analysis contingent on surviving to 12 months after screening was completed, accounting for competing risk of mortality.Results
During follow-up of 153,311 men tested by DXA and 390,158 controls, 56,083 (10.3%) had sustained a fracture and 111,774 (20.6%) died. Overall, DXA testing was not associated with a decrease in fractures; conclusions are limited by unmeasured confounders and low medication initiation and adherence in those meeting treatment thresholds (12% of follow-up time). In contrast, DXA testing in prespecified subgroups was associated with a lower risk of fracture in comparison to the overall population who underwent DXA testing: androgen deprivation therapy (hazard ratio [HR], 0.77; 95% CI, 0.66-0.89), glucocorticoids (HR, 0.77; 95% CI, 0.72-0.84), age 80 years and older (HR, 0.85; 0.81-0.90), 1 or more VA guideline risk factors (HR, 0.91; 95% CI, 0.87-0.95), and high Fracture Risk Assessment Tool using body mass index score (HR, 0.90; 95% CI, 0.86-0.95).Conclusion
Current VA DXA testing practices are ineffective overall; interventions to improve treatment adherence are needed. Targeted DXA testing in higher-risk men was associated with a lower fracture risk. 相似文献997.
目的:探讨2型糖尿病(T2DM)患者血糖控制水平对骨密度的影响。方法:纳入T2DM患者170例,其中绝经前女性T2DM患者(A1组)21例,绝经后女性T2DM患者(A2组)79例,小于50岁男性T2DM患者(B1组)22例,50岁及以上男性T2DM患者(B2组)48例。应用双能X线骨密度仪测定所有患者腰椎(L2、L3、L4和L2~4)及股骨近端[(股骨颈(FN)、大转子(TM)和Wards三角区(WA)]的骨密度。以各部位骨密度为因变量,以糖化血红蛋白(Hb A1c)、年龄、体重指数、病程等可能影响骨密度的因素为自变量,建立多重线性回归模型,分析血糖控制水平是否对T2DM患者骨密度有影响。结果:A1组未发现Hb A1c水平对骨密度有影响。A2组中Hb A1c水平对L2、L3、L4和L2~4的骨密度有影响(β=-0.579、-0.556、-0.614和-0.476,P均<0.05)。B1组中Hb A1c水平对L4、L2~4和WA的骨密度有影响(β=-0.443、-0.284和-0.227,P均<0.05)。B2组中Hb A1c水平对L4、L2~4和TM的骨密度有影响(β=-0.745、-0.297和-0.147,P均<0.05)。结论:T2DM患者血糖控制水平是骨密度的影响因素,尤其是对于男性及绝经后女性患者。 相似文献
998.
High‐density mapping for catheter ablation of premature ventricular complexes originating from left ventricular papillary muscles: A case series 下载免费PDF全文
999.
目的:通过2种分离培养方法所得骨髓间充质干细胞(MSCs)的生长特征和微环境中细胞因子的比较,提供一种可以快速、安全、高效地为临床和实验提供大量优质MSCs的方法。方法提取C57BL/c小鼠的骨髓,分别作密度梯度离心法和全骨髓贴壁培养分离法分离培养MSCs ,通过流式细胞仪检测细胞表面CD29+、CD31-、CD34-、CD45-表达水平,并比较各自所得细胞的生长曲线;ELISA检测培养液中的血管内皮生长因子(VEGF)、SDF‐1α浓度并比较二者的差异。结果与密度梯度离心法比较,全骨髓贴壁分离法所得原代细胞有较快的生长速度,较短的生长周期;培养液中VEGF和SDF‐1α浓度也稍高于密度梯度离心法。结论全骨髓贴壁培养法可以快速、方便、有效地为临床和实验提供大量MSCs ,所得细胞的培养环境优于密度梯度离心法,减少了对细胞功能的损害。 相似文献
1000.
目的:建立人结肠癌鸡胚移植模型,研究龙葵碱对其血管生成的影响。方法将鸡胚分为对照组和低剂量组、中剂量组、高剂量组(均n=10),将培养的人结肠癌细胞系HT‐29细胞株接种到鸡胚绒毛尿囊膜(CAM)上,通过立体显微镜、Image‐proplus6.0图像分析软件及免疫组织化学苏木精‐伊红(HE)染色法,观察移植瘤在CAM上血管生成的特点,及不同龙葵碱剂量对血管生成的影响。结果HT‐29细胞接种到CAM第3~5天,大量血管向瘤体集中,长入或跨越瘤体表面,肿瘤迅速生长。给药后第5天进行拍照,图像分析,定量计算血管新生面积明显低于对照组,且呈剂量依赖性,各组间差异有统计学意义(P<0.01)。免疫组织化学检测表明不同剂量龙葵碱的微血管密度明显低于对照组,与血管新生面积相一致;ki‐67抗原表达指数逐渐下降,实验组低于对照组,且各组间差异有统计学意义(P<0.01)。结论龙葵碱能明显抑制人结肠癌HT‐29细胞株诱导的血管生成,从而抑制肿瘤的生长,为抗肿瘤血管生成的治疗方面提供了重要依据。 相似文献